AUSTIN, TX – February 5, 2015 - Aratana Therapeutics, Inc. (PETX) announced on December 18th the positive, statistically-significant (p<0.05) results from its pivotal field study of AT-001 (Grapiprant), the company’s innovative drug for treating pain in dogs with osteoarthritis. This was just the latest pivotal study to use the VISION electronic data capture system, developed by Austin-based Prelude Dynamics. VISION was key to the conduct of the study.
“Using VISION to monitor the data in real-time, search data and create reports within the system to monitor progress was definitely instrumental in making the study run smoothly and efficiently,” said Dr. Johnny Jacobsen, Chief Operating Officer at AlcheraBio LLC, the clinical research organization that managed the study. Study sites and AlcheraBio personnel find VISION intuitive and easy to navigate.
“VISION’s strength is its ability to automate the intricacies of the study for complex protocols beyond what sponsors typically expect,” said Prelude Dynamics CTO, Dr. Alicia Browner. VISION has a library of customizable features that allow for these expedited timelines. For Aratana’s AT-003 study, assessments could be selectively hidden from view of the assessor when complete; integrated inventory-tracking streamlines the drug reconciliation process; Con Meds and AEs are cross-referenced; complex cross-form constraints and calculations are easily configured. All information is easily accessible directly on the page that holds the data, such as queries, notes-to-file, errors, and audit trail. Real-time remote access to data enables Monitors to query specific data, automatically notifying the site to review and respond. This built-in exchange allows data reviews to occur much closer to the actual data collection time.
“The fact that Aratana was able to lock the database and release their results simultaneously shows the quality of the data they collected and analyzed using VISION,” said Richard Tieken, Prelude Dynamics CEO. This allows for studies to consistently close out months ahead of schedule. Where it may have taken months to clean and lock the entire data set, with VISION it takes days. Prelude’s services have benefited sponsors in hundreds of human, companion animal, and food animal clinical trials in all Phases, across 25 countries, in multiple languages with hundreds of sites and thousands of patients.
About Prelude Dynamics
Prelude Dynamics is an industry leader at providing innovative software-as-a-service technology solutions for clinical trials across the globe. The company’s flagship product, VISION, offers secure and configurable data capture and information awareness tools for the advancement of human and animal health, compliant with FDA/CVM and EMEA regulations. VISION facilitates real-time data collection, querying, cleaning, reporting, and analysis all based on the needs of the researchers. The company was established in 2003 with a goal to speed the study process, improve data quality, and facilitate easy data entry through automation. See the website at: PreludeDynamics.com
Trademarks
VISION is a registered trademark of Prelude Dynamics, LLC. Other names may be trademarks of their respective owners.
Contact
Jim Pedzinski
VP of Business Development
jpedzinski@preludedynamics.com
512-476-5100 ext. 210
3906 Manchaca Rd.
Austin, TX 78704
Help employers find you! Check out all the jobs and post your resume.
